JP Patent

JP7406008B2 — Ｃｄｋ９阻害剤としての多環式アミド系誘導体、その調製方法及び用途

Assigned to Suzhou Alphama Biotechnology Co Ltd · Expires 2023-12-26 · 2y expired

What this patent protects

Patent listed against ribociclib-succinate.

Drugs covered by this patent

ribociclib-succinate (RIBOCICLIB SUCCINATE)

Patent Metadata

Patent number: JP7406008B2
Jurisdiction: JP
Classification: —
Expires: 2023-12-26
Drug substance claim: No
Drug product claim: No
Assignee: Suzhou Alphama Biotechnology Co Ltd
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.